Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 43598-330

This is the description of a medication called Zoledronic Acid Injection. It is a concentrate for intravenous infusion contained in a 5mL single-use vial. The medication must be diluted and not injected directly. The package insert should be consulted for dosage and administration information. The medication should not be mixed with calcium-containing infusion solutions. The medication can be stored in a refrigerator at 3-25°C. The solution must be prepared according to package instructions and must be administered within 2 hours after the dilution. The medication is produced by Gland Pharma Limited in India and marketed by Dr. Reddy's Laboratories Limited under the trademark NOVAPLUS.*

The text provides visual data in the form of a chart that shows the proportion of complete responders by day 10 in X6 Pooled HCM Studies. The chart compares the results of Zoledronic Acid injection (n=99) and Pamidronate 90 mg injection (n=86). The data suggests that Zoledronic Acid injection has a higher proportion of complete responders by day 10 compared to Pamidronate injection.*

This is a description of a medicine called Zoledronic Acid Injection that is available only on prescription. It comes in a 5 mL single-use vial and is concentrated for intravenous infusion. The medicine is made by NOVAPLUS and has a specific NDC (National Drug Code) number. The rest of the text appears to be identifying marks related to the packaging and may not be useful in understanding the product itself.*